VRTX
Search by
TICKER SYMBOL
TICKER SYMBOL
OptionsHawk Content
Large Cap Biotech with Relative Strength Gearing up for Breakout
Mar 04, 2025
Vertex Pharma (VRTX) shares are flagging nicely near recent highs and have stayed wildly strong relative to the broad market. VRTX can break out above...
Relative Strength Large Cap Biotech Name with Bull Flag Setup
Aug 21, 2023
Vertex Pharma (VRTX) shares closed on highs Monday back above the 8 and 21 EMA’s as it tries to take out a small trendline from...
Seasonal Stock Setup: Biotech Innovator Showing Relative Strength off Key Support
May 25, 2022
Vertex Pharma (VRTX) – VRTX is a $68.66B global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases....
Management Commentary 1-26-2022
Jan 26, 2022
Abbott Labs (ABT) earnings call on Libre growth and drivers… “It continues to grow at a very strong rate and a very large base. 35...
Management Commentary 1-10-2022
Jan 10, 2022
Vertex (VRTX) at JPM Healthcare Conference on CF program and Phase 3 milestones… “And in 2021, we also achieved important risk-lowering milestones in progress in...
Q3 Quarterly Insider Notable Activity ($500K+)
Sep 26, 2021
Trade Date Ticker Insider Name Title Price Qty Value 9/8/2021 ASAN Moskovitz Dustin A. Pres, CEO, Chair, 10% $96.49 750,000 $72,367,611 7/28/2021 SUI Shiffman Gary A COB,...
Insiders Active in Laggard Biotech with Cash-Rich Legacy Franchise and Plenty of Spending Power
Aug 04, 2021
Vertex (VRTX) sizable insider buy this week from director Bruce Sachs of 15,000 shares at $197.91, a more than $2.965M purchase. This is the largest –...
Translate Bio an Attractively Value Small Cap Biotech with a Promising mRNA Platform
Apr 25, 2021
Translate Bio (TBIO) screened among the more intriguing small cap Biotech stocks into 2021 and shares at +17% YTD versus the XBI at -4.6% have...